MedTrace Logo

Diagnostic Value of the Biofire®in Community Acquired Pneumonia

NCT06428318 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-05-29

No results posted yet for this study

Summary

This study aimed to determine the impact value of the BioFire FilmArray Pneumonia panel compared to conventional sputum culture in critically ill patients with pneumonia.

Conditions

Interventions

DIAGNOSTIC_TEST

Conventional Sputum culture

Sputum culture was done to patients and they received Antibiotics According to its results

DIAGNOSTIC_TEST

BioFire Pneumonia Panel (BFPP)

BioFire Pneumonia Panel (BFPP) was done to patients and they received Antibiotics According to its results

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-15
Primary Completion
2024-04-30
Completion
2024-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06428318 on ClinicalTrials.gov